Inflammatory biomarkers may aid patient selection in Ankylosing Spondylitis

11 April 2008 Print this article Comments Share this article
Significant reductions in disease activity biomarkers following infliximab therapy may help predict patients who are likely to respond, according to a recent study....

Want to read complete article? Please Sign in or Register.

Most viewed articles this week

Recent comments

Related sites